ArticleHealth science reports2026
A Two-Stage Hybrid Feature Selection and Ensemble Learning Framework With Explainable AI for Accurate PCOS Prediction.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Polycystic ovary syndrome (PCOS) is the most prevalent endocrine ailment impacting women of reproductive age, distinguished by ongoing imbalances of hormones that lead to the growth of various ovarian cysts alongside other health issues. Infrequent or delayed menstrual periods, and also frequently excessive amounts of androgen, a male hormone, are characteristics of women with PCOS. Despite other consequences, this disease may lead to weight gain, undesirable body hair, type 2 diabetes, and gestational diabetes. The number of cases of PCOS has shockingly ascended in the past few years, according to statistics. But the clinical diagnosis procedure for PCOS in the real world becomes critical since the precision of interpretations greatly relies on the knowledge of the doctor. Therefore, a PCOS prediction model using artificial intelligence might be an appropriate supplement to the lengthy and error-prone diagnosis method. Methods: To strictly prevent data leakage, the dataset underwent an 80/20 train-test split before applying SMOTE and two-stage feature selection exclusively to the training data. This framework combined Chi-Square filtering with Recursive Feature Elimination to identify the most pertinent features. A hybrid XGBoost (XGB) and Multi-Layer Perceptron (MLP) ensemble was selected from multiple machine learning models following rigorous evaluation using 10-fold stratified cross-validation. Finally, SHapley Additive exPlanations and Local Interpretable Model-Agnostic Explanations were integrated to significantly enhance overall model transparency. Results: The hybrid ensemble model (XGB + MLP) outperformed conventional single ML models, with the greatest classification accuracy of 96.33% among all evaluated models. The model's interpretability and performance were greatly enhanced by the 16 characteristics that were chosen. Conclusion: Combining hybrid ensemble learning, two-stage feature selection, and XAI approaches provides a computationally efficient, dependable, and interpretable method for PCOS diagnosis. Practitioners may find this model to be a useful decision-support tool that improves the accuracy of diagnosis and lessens the need for human interpretation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.